Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-Week, Blinded, Randomized, Placebo-Controlled Dose-Ranging Trial of Nasal PYY3-36 for Weight Loss in Healthy Obese Patients

NCT00537420 is registered in ClinicalTrials.gov with Nastech Pharmaceutical Company, Inc. as lead sponsor.

NCT NCT00537420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-Week, Blinded, Randomized, Placebo-Controlled Dose-Ranging Trial of Nasal PYY3-36 for Weight Loss in Healthy Obese Patients
Lead sponsor
Nastech Pharmaceutical Company, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
September 30, 2008
Enrollment
551 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

obesity